PYC Therapeutics LimitedASX: PYC

PKD - Presentation of Clinical Safety Data

· Issued by PYC Therapeutics Limited via ASX

Filed with ASX ·

pyctx.com | ACN 098 391 961 1 31 August 2026 POLYCYSTIC KIDNEY DISEASE – PRESENTATION OF CLINICAL SAFETY DATA • PYC is a precision medicine company dedicated to changing the lives of patients with genetic diseases who have no treatment options available • The Company is...

View Attachment

6ix hasn’t read this filing yet.

PYC Therapeutics Limited on 6ix

Story so far

Earlier from PYC Therapeutics

Later from PYC Therapeutics

All PYC Therapeutics news releases